Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Teligent Pharma, Inc. | Buena, New Jersey, United States | Makes it | Serious problems, FDA actionAug 31, 2021 · 8 inspections, 1 with FDA action |
Recalls
- Mar 15, 2022 · Class II · Teligent Pharma, Inc.
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Lots: Batch: a) 15496, Exp. 4/30/2022; 16347, Exp. 1/31/2023; b) 15496, Exp. 4/30/2022; 16298, Exp. 1/31/2023; c) 15496, Exp. 4/30/2022; 16298, Exp. 1/31/2023 - Apr 7, 2017 · Class III · Teligent, Inc.
Superpotent Drug
Lots: Lot #: 5760, Exp. 5/31/2018
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Desoximetasone: every company that makes it
- Form
- ointment
- Strength
- 2.5 mg per 1 g
- Approval
- ANDA ANDA208101
- On the market since
- Feb 25, 2016
- Package NDCs
52565-030-1552565-030-6052565-030-99- Official label
- DailyMed (National Library of Medicine), updated Feb 25, 2016
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?